A Safety, Efficacy Study of CombiflexOmega Peri Versus SmofKabiven Peripheral in Patients With Parenteral Nutrition

NCT01533298 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Parent

Interventions

DRUG: CombiflexOmega peri
DRUG: SmofKabiven peripheral

Sponsor

JW Life Science